MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-09
DOI
10.1186/s13045-021-01111-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic importance of BCR-ABL transcripts in Chronic Myeloid Leukemia; a systematic review and meta-analysis
- (2021) Omid Kiani Ghalesardi et al. LEUKEMIA RESEARCH
- Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
- (2021) Sarah K. Madden et al. Molecular Cancer
- Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
- (2021) Marc-Andrea Baertsch et al. Blood Cancer Journal
- Abrogation of histone deacetylases (HDACs) decreases survival of chronic myeloid leukemia cells: New insight into attenuating effects of the PI3K/c‐Myc axis on panobinostat cytotoxicity
- (2021) Sara Zehtabcheh et al. CELL BIOLOGY INTERNATIONAL
- Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
- (2021) W. Douglas Fairlie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
- (2021) Anita Csizmarik et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
- (2021) Mehrdad Izadirad et al. DRUG DISCOVERY TODAY
- Gene Transactivation and Transrepression in MYC-Driven Cancers
- (2021) Marika Scafuro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GSK-3: a multifaceted player in acute leukemias
- (2021) Alberto M. Martelli et al. LEUKEMIA
- Double-Hit and Triple-Hit Follicular Lymphoma
- (2020) Jessica B Ziemba et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Inhibition of Myc Transcriptional Activity by a Mini Protein Based Upon Mxd1
- (2020) Mark J. Demma et al. FEBS LETTERS
- Enhancers and MYC interplay in hematopoiesis
- (2020) Leonidas Benetatos et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Transcription Factor Inhibition: Lessons Learned and Emerging Targets
- (2020) Andrew Chen et al. TRENDS IN MOLECULAR MEDICINE
- Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells
- (2020) Leilei Zhang et al. Cell Death & Disease
- Re-epithelialization and immune cell behaviour in an ex vivo human skin model
- (2020) Ana Rakita et al. Scientific Reports
- ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia
- (2020) Adrián Montaño et al. Cells
- MYC’s Fine Line Between B Cell Development and Malignancy
- (2020) Oriol de Barrios et al. Cells
- Protein homodimer sequestration with small molecules: Focus on PD-L1
- (2020) Christian Bailly et al. BIOCHEMICAL PHARMACOLOGY
- Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
- (2020) Hamish S Scott et al. BLOOD
- MECOM rearrangement involving the MYC locus: two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review
- (2020) Scott C. Smith et al. LEUKEMIA RESEARCH
- MYC protein stability is negatively regulated by BRD4
- (2020) Ballachanda N. Devaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene
- (2020) Alessandro Liquori et al. Cancers
- Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
- (2020) Daniel Massó-Vallés et al. Cells
- c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis
- (2020) Mohammad Sayyadi et al. ARCHIVES OF MEDICAL RESEARCH
- MYC-induced human acute myeloid leukemia requires a continuing IL3/GM-CSF co-stimulus
- (2020) Elizabeth Bulaeva et al. BLOOD
- A Phase 1b/2a Study of the Pan-BET Bromodomain Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer
- (2020) Rahul R. Aggarwal et al. CLINICAL CANCER RESEARCH
- Incidence of single hit Bcl-2 and Bcl-6 rearrangements in DLBCL: the Irish experience
- (2020) Kate Dinneen et al. JOURNAL OF CLINICAL PATHOLOGY
- Emerging therapies in mantle cell lymphoma
- (2020) Walter Hanel et al. Journal of Hematology & Oncology
- Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
- (2020) Flávia Alves Verza et al. Cancers
- EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis
- (2020) Ayaka Yamaoka et al. Blood Advances
- Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma
- (2020) Nadine Abdallah et al. CLINICAL CANCER RESEARCH
- The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells
- (2020) Dalal AlSultan et al. INVESTIGATIONAL NEW DRUGS
- CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia
- (2020) Melinda A. Biernacki et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
- (2020) Jonas Ecker et al. NEURO-ONCOLOGY
- Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
- (2020) Wen Shuai et al. Blood Cancer Journal
- Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
- (2020) Sagarajit Mohanty et al. Cancers
- Ligand-based optimization and biological evaluation of N-(2,2,2-trichloro-1-(3-phenylthioureido)ethyl)acetamide derivatives as potent intrinsically disordered protein c-Myc inhibitors
- (2020) Limin Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
- (2020) Geoffrey I. Shapiro et al. BRITISH JOURNAL OF CANCER
- AML1-ETO inhibits acute myeloid leukemia immune escape by CD48
- (2020) Zhiding Wang et al. LEUKEMIA & LYMPHOMA
- How I diagnose and treat NPM1-mutated AML
- (2020) Brunangelo Falini et al. BLOOD
- Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
- (2019) Kamal Chamoun et al. Journal of Hematology & Oncology
- NUP214 in Leukemia: It’s More than Transport
- (2019) Adélia Mendes et al. Cells
- MYC Oncogene Contributions to Release of Cell Cycle Brakes
- (2019) Lucía García-Gutiérrez et al. Genes
- Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
- (2019) Marie-Eve Beaulieu et al. Science Translational Medicine
- CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway
- (2019) Hongyan Ji et al. PEDIATRIC RESEARCH
- Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions
- (2019) Claus Meyer et al. LEUKEMIA
- γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia
- (2019) Noemie Luong-Gardiol et al. CANCER CELL
- MYC modulators in cancer: a patent review
- (2019) Xiao-Na Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- MYC as a therapeutic target for the treatment of triple-negative breast cancer.
- (2019) Sarah A. Foley et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic leukemia cells
- (2019) Negar Sheikh‐Zeineddini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models
- (2019) Lucile Astorgues-Xerri et al. LEUKEMIA & LYMPHOMA
- An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process
- (2019) Jihao Zhou et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
- (2019) Brittany L. Allen-Petersen et al. BIODRUGS
- MYC dysregulation in the progression of multiple myeloma
- (2019) Kristine Misund et al. LEUKEMIA
- Oncogenic MYC amplifies mitotic perturbations
- (2019) Samantha Littler et al. Open Biology
- BCR-ABL1+ AML De Novo and CBF-Leukemia at Relapse: Game of Clones
- (2019) Olga Kulemina et al. BLOOD
- PP2A Activators Enhance Efficacy of FLT3 Inhibitors in FLT3-ITD Acute Myeloid Leukemia Cells through AKT Inactivation-Dependent Pim-1 and c-Myc Proteasomal Degradation
- (2019) Mario Scarpa et al. BLOOD
- Phase 1 Dose Escalation and Expansion Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BET Inhibitor FT-1101 As a Single Agent in Patients with Relapsed or Refractory Hematologic Malignancies
- (2019) Manish R. Patel et al. BLOOD
- Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
- (2019) Huiying Han et al. CANCER CELL
- Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
- (2019) Beatrice Del Papa et al. CLINICAL CANCER RESEARCH
- IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
- (2019) Emelie Curovic Rotbain et al. HAEMATOLOGICA
- The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies
- (2019) Daniel Filip et al. LEUKEMIA & LYMPHOMA
- Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics
- (2019) Helen E. Speedy et al. Nature Communications
- Classification of aggressive and classic mantle cell lymphomas using synchrotron Fourier Transform Infrared microspectroscopy
- (2019) Magdalena Kolodziej et al. Scientific Reports
- HDAC Inhibitors in Acute Myeloid Leukemia
- (2019) San José-Enériz et al. Cancers
- Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia
- (2019) Eleonora Mäkelä et al. Cancers
- Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
- (2019) Valeria Visconte et al. Cancers
- Wnt Signalling in Acute Myeloid Leukaemia
- (2019) Alicja M. Gruszka et al. Cells
- Follicular lymphoma: 2020 update on diagnosis and management
- (2019) Arnold Freedman et al. AMERICAN JOURNAL OF HEMATOLOGY
- Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA
- (2019) Aaron J. Miller et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer
- (2019) Udom Lao-On et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- G‐Quadruplex‐Binding Small Molecule Induces Synthetic Lethality in Breast Cancer Cells by Inhibiting c‐MYC and BCL2 Expression
- (2019) Rakesh Paul et al. CHEMBIOCHEM
- The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment
- (2019) Ekaterina Kim et al. LEUKEMIA
- The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities
- (2019) Nithya Mudgapalli et al. MOLECULAR ASPECTS OF MEDICINE
- The co-occurrence of driver mutations in chronic myeloproliferative neoplasms
- (2018) Prajwal Boddu et al. ANNALS OF HEMATOLOGY
- 41OA phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma
- (2018) K A Blum et al. ANNALS OF ONCOLOGY
- Five percent of healthy newborns have anETV6-RUNX1fusion as revealed by DNA-based GIPFEL screening
- (2018) Daniel Schäfer et al. BLOOD
- Biology and treatment of Richter syndrome
- (2018) Davide Rossi et al. BLOOD
- Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases
- (2018) Nerea Vega-García et al. BRITISH JOURNAL OF HAEMATOLOGY
- Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition inFLT3-Mutant Acute Myeloid Leukemia
- (2018) Xuejie Jiang et al. CLINICAL CANCER RESEARCH
- Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2
- (2018) Tomoko Takimoto-Shimomura et al. INVESTIGATIONAL NEW DRUGS
- Polη, a Y-family translesion synthesis polymerase, promotes cellular tolerance of Myc-induced replication stress
- (2018) Kiminori Kurashima et al. JOURNAL OF CELL SCIENCE
- Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
- (2018) Jeremy Lewin et al. JOURNAL OF CLINICAL ONCOLOGY
- MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences
- (2018) Alberto L′Abbate et al. LEUKEMIA
- Targeting MYC in multiple myeloma
- (2018) K. K. Jovanović et al. LEUKEMIA
- MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
- (2018) Ying Zhang et al. Molecular Cancer
- APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells
- (2018) Andrea Local et al. MOLECULAR CANCER THERAPEUTICS
- Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy
- (2018) Jan A. Burger et al. Nature Reviews Clinical Oncology
- The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
- (2018) Daniel Gerlach et al. ONCOGENE
- The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia
- (2018) Akihiko Numata et al. Nature Communications
- De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
- (2018) Axel Hyrenius-Wittsten et al. Nature Communications
- Structural absorption by barbule microstructures of super black bird of paradise feathers
- (2018) Dakota E. McCoy et al. Nature Communications
- SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer
- (2018) Khaldoun Rifaï et al. Oncotarget
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
- (2018) Uri Rozovski et al. ACTA HAEMATOLOGICA
- Patterns of mutations in TP53 mutated AML
- (2018) John S. Welch BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer
- (2018) Ashvinikumar V. Gavai et al. CANCER RESEARCH
- MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells
- (2018) Katerina Cerna et al. LEUKEMIA
- A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
- (2018) Carsten Bahr et al. NATURE
- Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
- (2018) Edina Wang et al. ONCOGENE
- The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
- (2018) Sean D. Reiff et al. Cancer Discovery
- 411OInitial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer
- (2018) J Hilton et al. ANNALS OF ONCOLOGY
- Potent anti‐proliferative effect of fatty‐acid derivative AIC ‐47 on leukemic mice harboring BCR ‐ ABL mutation
- (2018) Haruka Shinohara et al. CANCER SCIENCE
- Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
- (2018) Natasha S. Anstee et al. CELL DEATH AND DIFFERENTIATION
- Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
- (2018) Lavinia Carabet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL
- (2018) Yixiang Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- t(3;8)(q26.2;q24) Often Leads to MECOM /MYC Rearrangement and is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression
- (2018) Guilin Tang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia
- (2018) Phyllis S. Y. Chong et al. ONCOGENE
- MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report
- (2018) Karim Rihawi et al. Translational Oncology
- Double-slit photoelectron interference in strong-field ionization of the neon dimer
- (2018) Maksim Kunitski et al. Nature Communications
- BET Inhibition Induces HEXIM1- and RAD51-Dependent Conflicts between Transcription and Replication
- (2018) Akhil Bowry et al. Cell Reports
- Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
- (2018) Kate E. Grimm et al. Annals of Diagnostic Pathology
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
- (2017) Yasuhiro Oki et al. HAEMATOLOGICA
- MYC expression and translocation analyses in low-grade and transformed follicular lymphoma
- (2017) Sietse M Aukema et al. HISTOPATHOLOGY
- MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma
- (2017) Wei-Ge Wang et al. HISTOPATHOLOGY
- Production of Anti-c-Myc Monoclonal Antibody Inhibiting DNA Binding of c-Myc and Max Dimer by Epitope Peptide–CpG-DNA–Liposome Complex Without Carriers
- (2017) Byoung Kwon Park et al. International Journal of Peptide Research and Therapeutics
- Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches
- (2017) S Pearson et al. LEUKEMIA
- The MLL recombinome of acute leukemias in 2017
- (2017) C Meyer et al. LEUKEMIA
- Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response
- (2017) Joshua R. Porter et al. MOLECULAR CELL
- Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth
- (2017) L C Lustig et al. ONCOGENE
- Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition
- (2017) T K Moyo et al. ONCOGENE
- Common nonmutationalNOTCH1activation in chronic lymphocytic leukemia
- (2017) Giulia Fabbri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
- (2017) Salomon Manier et al. Science Translational Medicine
- Role of PLZF as a tumor suppressor in prostate cancer
- (2017) Yang Jin et al. Oncotarget
- CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
- (2017) Yasuhiro Oki et al. HAEMATOLOGICA
- The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
- (2017) Lynh Nguyen et al. Genes
- Overview of the Use of Murine Models in Leukemia and Lymphoma Research
- (2017) Rebecca Kohnken et al. Frontiers in Oncology
- Activation of apoptosis signalling pathways by reactive oxygen species
- (2016) Maureen Redza-Dutordoir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL
- (2016) Annalisa D’Avola et al. BLOOD
- BCR inhibitor failure in CLL: an unmet need
- (2016) N. Jain et al. BLOOD
- Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
- (2016) Changchun Deng et al. BLOOD
- Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
- (2016) A. R. Mato et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia
- (2016) Mindaugas Stoskus et al. BLOOD CELLS MOLECULES AND DISEASES
- Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells
- (2016) Haruka Shinohara et al. CANCER LETTERS
- TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth
- (2016) Savvas C. Pavlides et al. CELL CYCLE
- The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair
- (2016) C Bassi et al. CELL DEATH AND DIFFERENTIATION
- Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
- (2016) Katelyn L. O'Neill et al. GENES & DEVELOPMENT
- B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4
- (2016) Stavroula Ntoufa et al. JOURNAL OF IMMUNOLOGY
- Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)
- (2016) Robert H. Bradbury et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
- (2016) K T Siu et al. LEUKEMIA
- Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC and can be targeted by SYK inhibition
- (2016) S Köhrer et al. LEUKEMIA
- Identification of MYC mutations in acute myeloid leukemias with NUP98–NSD1 translocations
- (2016) V-P Lavallée et al. LEUKEMIA
- The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia
- (2016) Yan Li et al. MODERN PATHOLOGY
- Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1
- (2016) Santiago Montes-Moreno et al. MODERN PATHOLOGY
- AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
- (2016) G. W. Rhyasen et al. MOLECULAR CANCER THERAPEUTICS
- Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-β-Mediated Induction of the CDK Inhibitor p15 Ink4B
- (2016) Xin-Hua Feng et al. MOLECULAR CELL
- Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate
- (2016) Michelle A. Hughes et al. MOLECULAR CELL
- Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
- (2016) Sheela A. Abraham et al. NATURE
- Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases
- (2016) Per Hydbring et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
- (2016) Ballachanda N Devaiah et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype
- (2016) Yang O. Huh et al. Cancer Genetics
- BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
- (2016) Ballachanda N Devaiah et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis
- (2016) Maria del Carmen Lafita-Navarro et al. Oncotarget
- Mutations in AML: prognostic and therapeutic implications
- (2016) C. D. DiNardo et al. Hematology-American Society of Hematology Education Program
- MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc
- (2016) Jialing Yuan et al. MEDICAL SCIENCE MONITOR
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
- (2016) Céline Berthon et al. Lancet Haematology
- p53 Pulses Diversify Target Gene Expression Dynamics in an mRNA Half-Life-Dependent Manner and Delineate Co-regulated Target Gene Subnetworks
- (2016) Joshua R. Porter et al. Cell Systems
- Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas
- (2015) Karen M. Chisholm et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Myc and its interactors take shape
- (2015) William B. Tu et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Small-molecule inhibitors of the Myc oncoprotein
- (2015) Steven Fletcher et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Myc and cell cycle control
- (2015) Gabriel Bretones et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The biology and treatment of plasmablastic lymphoma
- (2015) J. J. Castillo et al. BLOOD
- Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
- (2015) A. Sanjuan-Pla et al. BLOOD
- Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation
- (2015) A. Yeomans et al. BLOOD
- Direct and indirect targeting of MYC to treat acute myeloid leukemia
- (2015) Sam Brondfield et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia
- (2015) Haruka Shinohara et al. CANCER LETTERS
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain
- (2015) K Schleich et al. CELL DEATH AND DIFFERENTIATION
- Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies
- (2015) Elodie Odore et al. CLINICAL PHARMACOKINETICS
- Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes
- (2015) G. C. Preston et al. EMBO JOURNAL
- Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc
- (2015) Y Liu et al. GENE THERAPY
- Perturbation of the c-Myc–Max Protein–Protein Interaction via Synthetic α-Helix Mimetics
- (2015) Kwan-Young Jung et al. JOURNAL OF MEDICINAL CHEMISTRY
- The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
- (2015) J Eswaran et al. LEUKEMIA
- The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity
- (2015) Fengmei Cui et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
- (2015) Nitesh Sharma et al. Molecular Cancer
- c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
- (2015) Nidal Muvarak et al. MOLECULAR CANCER RESEARCH
- MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
- (2015) Gero Doose et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mantle cell lymphoma—a spectrum from indolent to aggressive disease
- (2015) Birgitta Sander et al. VIRCHOWS ARCHIV
- The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
- (2015) B Barneda-Zahonero et al. Cell Death & Disease
- miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth
- (2015) Marija Mihailovich et al. Nature Communications
- Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas
- (2015) Yari Ciribilli et al. Oncotarget
- BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
- (2015) Marie-Magdelaine Coudé et al. Oncotarget
- CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients
- (2015) Na Xu et al. Journal of Cancer
- CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
- (2015) G P Gregory et al. LEUKEMIA
- Combination of PIM and JAK2 inhibitors synergistically suppresses cell proliferation and overcomes drug resistance of myeloproliferative neoplasms
- (2015) Shih-Min A. Huang et al. Oncotarget
- MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation
- (2015) Yuhuang Li et al. Oncotarget
- c-Myc Suppression of DNA Double-strand Break Repair
- (2015) Zhaozhong Li et al. NEOPLASIA
- γ-Catenin at Adherens Junctions: Mechanism and Biologic Implications in Hepatocellular Cancer after β-Catenin Knockdown
- (2015) Emily Diane Wickline et al. NEOPLASIA
- Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression
- (2014) Hongliang Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
- (2014) M. Mraz et al. BLOOD
- A phase 1 study of the PI3K inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
- (2014) B. S. Kahl et al. BLOOD
- c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis
- (2014) A. Nanbakhsh et al. BLOOD
- AML drug resistance: c-Myc comes into play
- (2014) C. Fauriat et al. BLOOD
- Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing MYC Expression
- (2014) C. T. Wallington-Beddoe et al. CANCER RESEARCH
- Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
- (2014) T J Phesse et al. CELL DEATH AND DIFFERENTIATION
- Regulation of c-Myc protein stability by proteasome activator REGγ
- (2014) S Li et al. CELL DEATH AND DIFFERENTIATION
- SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells
- (2014) Ling Li et al. Cell Stem Cell
- Discovery of Methyl 4′-Methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate, an Improved Small-Molecule Inhibitor of c-Myc-Max Dimerization
- (2014) Jay Chauhan et al. ChemMedChem
- B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells
- (2014) Vaclav Seda et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
- (2014) Dimitris Stellas et al. JNCI-Journal of the National Cancer Institute
- The clinical significance of ABCC3 as an imatinib transporter in chronic myeloid leukaemia
- (2014) A Giannoudis et al. LEUKEMIA
- TP53mutations are frequent events in double-hit B-cell lymphomas withMYCandBCL2but notMYCandBCL6translocations
- (2014) Niklas Gebauer et al. LEUKEMIA & LYMPHOMA
- C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
- (2014) Ashleigh Allen et al. LEUKEMIA RESEARCH
- Inhibitor of MYC identified in a Krohnke pyridine library
- (2014) J. R. Hart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid Tissues
- (2014) Nathiya Muthalagu et al. Cell Reports
- MYC Degradation
- (2014) A. S. Farrell et al. Cold Spring Harbor Perspectives in Medicine
- Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas
- (2013) J. Shortt et al. BLOOD
- The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop
- (2013) J. N. Psathas et al. BLOOD
- STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia
- (2013) M. Mangolini et al. BLOOD
- Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
- (2013) Matthew Brentnall et al. BMC CELL BIOLOGY
- Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls
- (2013) Martin J. S. Dyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
- (2013) Linsey Reavie et al. CANCER CELL
- Cell cycle regulation by long non-coding RNAs
- (2013) Masatoshi Kitagawa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hematopoiesis
- (2013) M. Jagannathan-Bogdan et al. DEVELOPMENT
- Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
- (2013) J. Shi et al. GENES & DEVELOPMENT
- MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) A. Valera et al. HAEMATOLOGICA
- Panta rhei: The APC/C at steady state
- (2013) Ivana Primorac et al. JOURNAL OF CELL BIOLOGY
- Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
- (2013) A. S. Farrell et al. MOLECULAR AND CELLULAR BIOLOGY
- PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
- (2013) M. Pfeifer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis
- (2013) A. I. Nieminen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P53 protein in proliferation, repair and apoptosis of cells
- (2013) Ewelina Wawryk-Gawda et al. PROTOPLASMA
- Transcriptional control of DNA replication licensing by Myc
- (2013) Taras Valovka et al. Scientific Reports
- The Role of MIZ-1 in MYC-Dependent Tumorigenesis
- (2013) K. E. Wiese et al. Cold Spring Harbor Perspectives in Medicine
- miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
- (2013) Laura Lupini et al. Frontiers in Genetics
- Antagonism between FOXO and MYC Regulates Cellular Powerhouse
- (2013) Barrie Peck et al. Frontiers in Oncology
- CDC25A: A Rebel Within the CDC25 Phosphatases Family?
- (2012) Anne Fernandez-Vidal et al. Anti-Cancer Agents in Medicinal Chemistry
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- (2012) C. J. Ott et al. BLOOD
- Blockade of miR-150 Maturation by MLL-Fusion/MYC/LIN-28 Is Required for MLL-Associated Leukemia
- (2012) Xi Jiang et al. CANCER CELL
- Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells
- (2012) W.-B. Tsai et al. CANCER RESEARCH
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
- (2012) Zuqin Nie et al. CELL
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Transcriptional regulation of thec-Mycpromoter by NFAT1 involves negative and positive NFAT-responsive elements
- (2012) Giuliana P. Mognol et al. CELL CYCLE
- MYC oncogene in myeloid neoplasias
- (2012) M. Dolores Delgado et al. Clinical & Translational Oncology
- Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
- (2012) C. Qian et al. CLINICAL CANCER RESEARCH
- Pirh2 RING-finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
- (2012) Yong-Sam Jung et al. FEBS LETTERS
- MLL–AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny
- (2012) S J Horton et al. LEUKEMIA
- MGA, a suppressor ofMYC, is recurrently inactivated in high risk chronic lymphocytic leukemia
- (2012) Lorenzo De Paoli et al. LEUKEMIA & LYMPHOMA
- Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21cip (CDKN1A)
- (2012) P.-P. Wong et al. MOLECULAR AND CELLULAR BIOLOGY
- The Super Elongation Complex Family of RNA Polymerase II Elongation Factors: Gene Target Specificity and Transcriptional Output
- (2012) Z. Luo et al. MOLECULAR AND CELLULAR BIOLOGY
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
- (2012) Roland Schmitz et al. NATURE
- The genetic landscape of mutations in Burkitt lymphoma
- (2012) Cassandra Love et al. NATURE GENETICS
- The super elongation complex (SEC) family in transcriptional control
- (2012) Zhuojuan Luo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity
- (2012) I Paul et al. ONCOGENE
- The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities
- (2012) Martin Montagne et al. PLoS One
- Polycomb repressive complex 2 is required for MLL-AF9 leukemia
- (2012) T. Neff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
- (2012) Stefano Campaner et al. Cell Division
- IGF2BP1
- (2012) Nadine Stöhr et al. Cell Adhesion & Migration
- Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy?
- (2012) N. Muvarak et al. Current Hematologic Malignancy Reports
- MicroRNAs and the cell cycle
- (2011) María José Bueno et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells
- (2011) S. Krysov et al. BLOOD
- Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
- (2011) C. M. Lucas et al. BLOOD
- Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression
- (2011) Joshua D. Schiffman et al. BRITISH JOURNAL OF HAEMATOLOGY
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The c-MYC-AP4-p21 cascade
- (2011) Peter Jung et al. CELL CYCLE
- Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters
- (2011) Chui-Sun Yap et al. CELL CYCLE
- FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression
- (2011) E C Ferber et al. CELL DEATH AND DIFFERENTIATION
- Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia
- (2011) A. Mummery et al. CURRENT CANCER DRUG TARGETS
- FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
- (2011) Kim Steen Jensen et al. EMBO JOURNAL
- Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts
- (2011) Kristiina Järvinen et al. EXPERIMENTAL CELL RESEARCH
- The R(h)oads to Stat3: Stat3 activation by the Rho GTPases
- (2011) Leda Raptis et al. EXPERIMENTAL CELL RESEARCH
- Entinostat for treatment of solid tumors and hematologic malignancies
- (2011) Jeffrey Knipstein et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1through SKP2 in Human Leukemia Cells
- (2011) Gabriel Bretones et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Romo1 is a negative-feedback regulator of Myc
- (2011) S. B. Lee et al. JOURNAL OF CELL SCIENCE
- TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties
- (2011) K C Goh et al. LEUKEMIA
- Ribosomal Protein L11 Recruits miR-24/miRISC To Repress c-Myc Expression in Response to Ribosomal Stress
- (2011) K. B. Challagundla et al. MOLECULAR AND CELLULAR BIOLOGY
- c-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia CD34+ Hematopoietic Progenitor Cells
- (2011) A. Porro et al. MOLECULAR CANCER RESEARCH
- MYC in Chronic Myeloid Leukemia: Induction of Aberrant DNA Synthesis and Association with Poor Response to Imatinib
- (2011) M. Albajar et al. MOLECULAR CANCER RESEARCH
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- E-box-independent regulation of transcription and differentiation by MYC
- (2011) Iris Uribesalgo et al. NATURE CELL BIOLOGY
- Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression
- (2011) Stefano Amente et al. NUCLEIC ACIDS RESEARCH
- Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts
- (2011) D Perna et al. ONCOGENE
- PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy
- (2011) Jianbiao Zhou et al. PLoS One
- c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance
- (2011) S. Pyndiah et al. Science Signaling
- The complex landscape of genetic alterations in mantle cell lymphoma
- (2011) Cristina Royo et al. SEMINARS IN CANCER BIOLOGY
- The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis—Binding Myc makes the difference
- (2011) Tarik Möröy et al. SEMINARS IN IMMUNOLOGY
- Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair
- (2011) Libing Song et al. Journal of Molecular Cell Biology
- Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
- (2011) Anne Hakem et al. PLoS Genetics
- IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas
- (2010) Alexandra Valera et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo
- (2010) S. Krysov et al. BLOOD
- FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
- (2010) Boyi Gan et al. CANCER CELL
- Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair
- (2010) K. R. Luoto et al. CANCER RESEARCH
- Identification of PP2A Complexes and Pathways Involved in Cell Transformation
- (2010) A. A. Sablina et al. CANCER RESEARCH
- Myc-Induced MicroRNAs Integrate Myc-Mediated Cell Proliferation and Cell Fate
- (2010) Jong Wook Kim et al. CANCER RESEARCH
- The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 Expression
- (2010) Piu Wong et al. CANCER RESEARCH
- A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs
- (2010) Jonghwan Kim et al. CELL
- c-Myc Regulates Transcriptional Pause Release
- (2010) Peter B. Rahl et al. CELL
- c-Myc protein is degraded in response to UV irradiation
- (2010) Sébastien Britton et al. CELL CYCLE
- Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis?
- (2010) Javier Leon et al. CELL CYCLE
- Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?
- (2010) Ian Cannell et al. CELL CYCLE
- Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells
- (2010) S. H. Choi et al. GENES & DEVELOPMENT
- Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia
- (2010) Zhifu Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- A Pediatric B Lineage Leukemia With Coincident MYC and MLL Translocations
- (2010) Nathan D. Meeker et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features
- (2010) Lekidelu Taddesse-Heath et al. MODERN PATHOLOGY
- Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas
- (2010) Adam C Seegmiller et al. MODERN PATHOLOGY
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses
- (2010) Delin Chen et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase–substrate complex
- (2010) Linsey Reavie et al. NATURE IMMUNOLOGY
- Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage
- (2010) Lina Guerra et al. PLoS One
- B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia
- (2010) W. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins
- (2010) V. Coelho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication
- (2010) I. G. Cannell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
- (2010) Robert B. Hamanaka et al. TRENDS IN BIOCHEMICAL SCIENCES
- Rho GTPases in hematopoiesis and hemopathies
- (2009) J. C. Mulloy et al. BLOOD
- c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors
- (2009) Y. Guo et al. BLOOD
- Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
- (2009) D. Drygin et al. CANCER RESEARCH
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
- The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage
- (2009) E K Cassimere et al. CELL DEATH AND DIFFERENTIATION
- The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc
- (2009) Hugh K Arnold et al. EMBO JOURNAL
- Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
- (2009) Eun-Woo Lee et al. EMBO JOURNAL
- Mitochondrial reactive oxygen species originating from Romo1 exert an important role in normal cell cycle progression by regulating p27Kip1expression
- (2009) Jin Sil Chung et al. FREE RADICAL RESEARCH
- HuR recruits let-7/RISC to repress c-Myc expression
- (2009) H. H. Kim et al. GENES & DEVELOPMENT
- miR-19 is a key oncogenic component of mir-17-92
- (2009) V. Olive et al. GENES & DEVELOPMENT
- Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein
- (2009) Jin Shi et al. INTERNATIONAL JOURNAL OF CANCER
- c-Myc-induced Aberrant DNA Synthesis and Activation of DNA Damage Response in p300 Knockdown Cells
- (2009) Natesan Sankar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy
- (2009) M Wang et al. LEUKEMIA
- miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
- (2009) M Mraz et al. LEUKEMIA
- Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics
- (2009) Cuiping Pan et al. MOLECULAR & CELLULAR PROTEOMICS
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Cyclin-dependent kinases: a family portrait
- (2009) Marcos Malumbres et al. NATURE CELL BIOLOGY
- MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
- (2009) L J Beverly et al. ONCOGENE
- c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
- (2009) Kristin Robinson et al. PLoS One
- p53 represses c-Myc through induction of the tumor suppressor miR-145
- (2009) M. Sachdeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How do microRNAs regulate gene expression?
- (2008) Ian G. Cannell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
- (2008) G. Wernig et al. BLOOD
- MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes
- (2008) M. Inomata et al. BLOOD
- MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
- (2008) Yang O. Huh et al. BRITISH JOURNAL OF HAEMATOLOGY
- HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma
- (2008) John D. Gordan et al. CANCER CELL
- Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair
- (2008) Annahita Sallmyr et al. CANCER LETTERS
- Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
- (2008) K. Kumamoto et al. CANCER RESEARCH
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
- (2008) C.-J. Lin et al. CANCER RESEARCH
- Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
- (2008) Stuart H. Orkin et al. CELL
- REGγ, a proteasome activator and beyond?
- (2008) I. Mao et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1
- (2008) Steffi Herold et al. EMBO JOURNAL
- Dynamic regulation ofc-Myc proto-oncogene expression during lymphocyte development revealed by aGFP-c-Myc knock-in mouse
- (2008) Ching-Yu Huang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia
- (2008) William E. Blanco-Bose et al. HEPATOLOGY
- c-Myc and Caspase-2 Are Involved in Activating Bax during Cytotoxic Drug-induced Apoptosis
- (2008) Xuefang Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cdk5-mediated Phosphorylation of c-Myc on Ser-62 Is Essential in Transcriptional Activation of Cyclin B1 by Cyclin G1
- (2008) Haeng Ran Seo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase
- (2008) Jonathan E. Grim et al. JOURNAL OF CELL BIOLOGY
- c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27Kip1 cyclin dependent kinase inhibitor
- (2008) Vidyalakshmi Chandramohan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Adenovirus E1A oncoprotein liberates c‐Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1‐dependent mechanism
- (2008) Erica L. Kinney et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
- (2008) Abdulwahab J. Al-Tourah et al. JOURNAL OF CLINICAL ONCOLOGY
- Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest
- (2008) J. C. Acosta et al. MOLECULAR AND CELLULAR BIOLOGY
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- Pim kinase-dependent inhibition of c-Myc degradation
- (2008) Y Zhang et al. ONCOGENE
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
- AP4 encodes a c-MYC-inducible repressor of p21
- (2008) P. Jung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene
- (2008) Yi Wen Kong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A microRNA DNA methylation signature for human cancer metastasis
- (2008) A. Lujambio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia
- (2007) Tanzina Chowdhury et al. BLOOD CELLS MOLECULES AND DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More